Stock analysts at Credit Suisse set a $8.00 price objective on shares of Ariad Pharmaceuticals (NASDAQ:ARIA) stock in a report issued on Friday, American Banking News.com reports. Credit Suisse’s price objective would indicate a potential upside of 11.58% from the stock’s previous close. Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA) stock opened at $7.65 in last trading session, and closed at $7.99, trading in the range of $7.40 – $8.29. The stock showed a positive weekly performance of 8.12%.
Activision Blizzard (NASDAQ:ATVI) announced a annual dividend on Friday, February 7th, AnalystRatingsNetwork.com reports. Investors of record on Wednesday, March 19th will be paid a dividend of 0.20 per share on Wednesday, May 14th. This represents a dividend yield of 1.02%. The ex-dividend date is Monday, March 17th. This is an increase from Activision Blizzard’s previous annual dividend of $0.19. Activision Blizzard, Inc. (NASDAQ:ATVI) shares closed at $19.64 on last trade day, by gaining 14.39%. Stock 52 week range is $12.90 – $19.95. Company’s market capitalization is $13.66 billion.
FBR Capital Markets raised their target price on shares of ON Semiconductor Corp. (NASDAQ:ONNN) from $10.50 to $11.00 in a research note issued on Friday, AnalystRatings.Net reports. FBR Capital Markets’ price objective indicates a potential upside of 32.21% from the company’s current price. ON Semiconductor Corp (NASDAQ:ONNN) stock advanced 8.59% and finished the last session at $9.03. The EPS of the stock remained -0.05. Company’s market capitalization is $4.02 billion.
TheStreet Quant Ratings rates Galena Biopharma Inc (NASDAQ:GALE) as a sell. The company’s weaknesses can be seen in multiple areas, such as its deteriorating net income, weak operating cash flow and feeble growth in its earnings per share. Galena Biopharma Inc (NASDAQ:GALE) stock opened at $4.31 in last trading session and closed at $4.93. The 52 week range of the stock is $1.65 – $7.77 and the day range was $4.30 – $5.02.